Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > No follow through

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 13, 2021 12:53am

194 Views

Post# 32282782

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:No follow through

What's it worth or what's it gonna cost?? Depends which pharma you ask. Stay rose rosy boy.

Redbaron2211 wrote: Thanks Stockhunter for those interested go to 8min on the video. Re: Hemophilia "This program is moving towards the Clinic".

Other interesting tid bits.

starting with 4000 transplants is relatively small and has potential to bring in over 300 million revenue. There are 50 million patients with TD1. We are looking at potential revenues in the 25-30 billion dollar range. What's that worth to big Pharma?